n/a
Article Publish Status: FREE
Abstract Title:

In vitro inhibitory activities of magnolol againstspp.

Abstract Source:

Drug Des Devel Ther. 2017 ;11:2653-2661. Epub 2017 Sep 6. PMID: 28919715

Abstract Author(s):

Peiru Zhou, Jingya Fu, Hong Hua, Xiaosong Liu

Article Affiliation:

Peiru Zhou

Abstract:

spp. cause various infections involving the skin, mucosa, deep tissues, and even life-threatening candidemia. They are regarded as an important pathogen of nosocomial bloodstream infection, with a high mortality rate. As a result of prolonged exposure to azoles, the therapeutic failure associated with azoles resistance has become a serious challenge in clinical situations. Therefore, novel, alternative antifungals are required urgently. In the present study, the CLSI M-27A broth microdilution method and the 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay were used to evaluate the antifungal effects of magnolol against various standardstrains in planktonic mode and biofilm formation, respectively. The antifungal activity of magnolol was demonstrated in planktonicand non-albicansspecies, especially fluconazole-resistant, with the minimum inhibitory concentrations ranging from 10 to 40μg/mL. The BMIC(minimum concentration with 90%biofilm inhibited) values of magnolol ranged from 20 to 160μg/mL, whereas the BMICvalues of fluconazole were more than 128μg/mL. As an alternative and broad-spectrum antifungal agent, magnolol might be of benefit to the treatment of refractoryinfection.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.